MS: from disease management to patient management
|
|
- Kory Lee
- 8 years ago
- Views:
Transcription
1 2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain May 2012
2 Dear Colleague On behalf of the Serono Symposia International Foundation we are delighted to welcome you to the 2012 annual continuing medical education (CME) accredited meeting: MS: from disease management to patient management. At this meeting, leading international experts will come together to discuss current and future approaches to the treatment of multiple sclerosis (MS). You will also have the opportunity to earn CME credits. This interactive meeting is divided into four sessions. Session 1 will cover the pharmacological targets of current and possible future therapies, and the requirement for close safety monitoring of newer therapies. In session 2 we will detail how the neurologist can best use the tools available for optimal diagnosis of MS and prediction of disease course. Session 3 will focus on current and future techniques to predict and monitor response to treatment, and in session 4 we will discuss the clinical management of MS, the relationship with the patient and how this can affect treatment adherence. Case studies will be presented, offering you the opportunity to discuss various aspects of clinical practice with the panel of experts. The aims of the 2012 annual conference are to provide an update on the latest understanding of MS pathophysiology and the mechanisms of action of current drugs, to discuss how best to diagnose patients and then predict and monitor treatment response, and to provide guidance on how best to ensure patients get optimal benefit from treatment. We anticipate that this programme will provide valuable updates for the clinician, and will stimulate engaging and enlightened debate on many of the complex issues surrounding the management of patients with MS. We hope that you will be able to join us and we look forward to your active participation. Yours sincerely, David Bates Newcastle upon Tyne, UK Xavier Montalban Barcelona, Spain All Serono Symposia International Foundation programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. All Serono Symposia International Foundation programs are made possible thanks to educational grants received from: Centre d Esclerosi Multiple de Catalunya, ComtecMed, Congrex Sweden, Congrex Switzerland, Cryo-Save, Datanalysis, Esaote, European Society of Endocrinology, Fondazione Humanitas, Fundación IVI, ISFP International Society for Fertility Preservation, ISMH International Society of Men s Health, K.I.T.E., Merck Serono, Sanofi-Aventis, University of Catania, Vall d Hebron University Hospital.
3 AIM OF THE CONFERENCE LEARNING OBJECTIVES TARGET AUDIENCE ACCREDITATION Research into the pathophysiology of multiple sclerosis (MS) and the mechanism of action of new drugs has, in recent years, produced a virtuous circle offering ever-new insights, enhancing our understanding of the disease and allowing optimization of treatment. The 2012 Serono Symposia International Foundation (SSIF) annual meeting will provide a review of these insights and offer the opportunity to discuss how to translate this increasing knowledge of management improvements for individual patients. By attending the conference, participants will: be updated on MS pathophysiology and modes of action of individual drugs discuss the use of standardized diagnostic criteria in daily practice improve their skills in sharing information with patients to increase adherence understand present and future biomarkers of response to treatment. Clinicians involved in MS management. An application has been made to the EACCME for CME accreditation of the MS: from disease management to patient management conference, to be held on May 2012 in Valencia, Spain. The official language of the conference will be English. REGISTRATION The full registration fee is 400,00 euro. For any registration requirements please contact Debora Urbinelli c/o Meridiano Congress International Tel. +39 (0) Fax +39 (0) d.urbinelli@meridiano.it 1
4 VENUE CHAIRS The conference will take place at: Meliá Valencia Palacio de Congresos Avenida Cortes Valencianas 52 Valencia, Spain David Bates Department of Neurology Royal Victoria Infirmary Newcastle upon Tyne, UK Xavier Montalban Multiple Sclerosis Centre of Catalonia Unit of Clinical Neuroimmunology Vall d Hebron University Hospital Barcelona, Spain SCIENTIFIC SECRETARIAT ORGANIZING SECRETARIAT Serono Symposia International Foundation Salita San Nicola da Tolentino, 1/B Rome, Italy Senior Project Manager, Neurology Team Leader: Serena Dell Ariccia Associate Project Manager: Alessia Addessi Phone: /591 Fax: info@seronosymposia.org Meridiano Congress International Via Mentana, 2/B Rome, Italy Congress Coordinator: Debora Urbinelli Phone: Mail: d.urbinelli@meridiano.it 2
5 Day 1 Friday, 18 May, SSIF Opening G. Comi (Italy) Local welcome Welcome and introduction D. Bates (UK) and X. Montalban (Spain) SCIENTIFIC PROGRAMME SESSION I Pharmacological targets and evolving pathophysiological concepts D. Bates (UK) L1 Improving understanding of mechanism of action of immunomodulatory drugs B. Kieseier (Germany) L2 Neuroprotection and neuroregeneration: the promising targets R. Gold (Germany) L3 Resetting the immune system: stem cell transplantation A. Uccelli (Italy) L4 Drug profile and efficacy G. Comi (Italy) L5 Safety assessment in practice P. Vermersch (France) Coffee break 3
6 SESSION II MS Diagnosis and prognosis X. Montalban (Spain) L6 McDonald criteria 2010: making the diagnosis easier A.J. Thompson (UK) L7 The diagnosis of MS before MS M. Tintorè (Spain) L8 What MRI is telling us about individual disease evolution? D. Arnold (Canada) Lunch C1 Case study: Differential diagnosis: NMO vs MS Presenter: speaker to be confirmed Discussants: L. Moiola (Italy) and B. Kieseier (Germany) SESSION III Treatment monitoring L9 Biomarkers G. Giovannoni (UK) L10 MRI as a potential marker of response A. Rovira (Spain) L11 Present and future roles of PGX J. Oksenberg (USA) Coffee break L12 Assessment of treatment response M. S. Freedman (Canada) C2 Case study: Treatment and treatment algorithms Presenter: G. Comi (Italy) Discussant: X. Montalban (Spain) End of the day 4
7 Day 2 Saturday, 19 May, 2012 SESSION IV From disease management to patient management G. Comi (Italy) L13 The patient s willingness to take risk B. Kieseier (Germany) L14 How to implement the partnership in clinical practice D. Langdon (UK) L15 Treatment adherence: how to measure it and how to improve it J. Sastre-Garriga (Spain) C3 Case study: Treatment failure due to lack of adherence Presenter: speaker to be confirmed Discussants: P. Rieckmann (Germany) and J. Sastre-Garriga (Spain) C4 Case study: How to improve outcomes tailoring treatment Presenter: D. Bates (UK) Discussants: G. Giovannoni (UK) and P. Vermersch (France) Concluding remarks End of the conference and closing lunch 5
8 Improving the patient s life through medical education Serono Symposia International Foundation Representative Office Salita di San Nicola da Tolentino 1/B Rome, Italy. T +39.(0) , F +39.(0) Headquarters 14, Rue du Rhone, 1204 Geneva, Switzerland Copyright Serono Symposia International Foundation, All rights reserved.
Milan, Italy - 24-25 October 2013
PRELIMINARY PROGRAMME Preceptorship on MRI in multiple sclerosis Milan, Italy - 24-25 October 2013 Aim of the course The goal of this activity is to educate physicians regarding the application and the
More information29 January 2016 - Rome, Italy
Updates on MS treatment management 29 January 2016 - Rome, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
More information5 February 2016 - Bari, Italy
Updates on MS treatment management 5 February 2016 - Bari, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
More information13 September 2016 - London, UK
INTERNATIONAL WORKSHOP PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 13 September 2016 - London, UK MS Academia - Multiple sclerosis advanced course Overview Multiple sclerosis
More informationVillejuif, Paris, France
SCIENTIFIC PROGRAMME 2014 Preceptorships in oncology Aim This live educational preceptorship aims to highlight the crucial role of the multidisciplinary approach in diagnosis, treatment and management
More informationI wish you an inspiring and successful learning experience here in Saint Petersburg. Yours Sincerely, Rachel Clark CEO, EXCEMED
Dear participant, A warm welcome to the "Advanced worshop in Embriology" event. I would like to inform you that as of 28 April 2014 the name of our Foundation changed to EXCEMED Excellence in Medical Education.
More informationXavier Montalban Barcelona, Spain
Abstract book 2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain 18-19 May 2012 Dear Colleague On behalf of the Serono Symposia International
More informationCalendar of events NEUROLOGY
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationGENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN PEOPLE WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN LARGE PHASE III STUDY
NEWS RELEASE Media Contact: Tara Iannuccillo (650) 467-6800 Investor Contacts: Stefan Foser Karl Mahler (650) 467-2016 011 41 61 687 8503 GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW
More informationPULMONARY HYPERTENSION. This meeting is fully sponsored by GlaxoSmithKline and jointly organised with the Meeting Faculty and GlaxoSmithKline
F O C U S O N PULMONARY HYPERTENSION B O L O G N A 2 0 1 0 1 5 y e a r s o n... p r o g r a m June 24-26, 2010 - Bologna, Italy This meeting is fully sponsored by GlaxoSmithKline and jointly organised
More informationDoubleTree by Hilton Hotel Zagreb, Ulica Grada Vukovara 269a, Zagreb, Croatia
March 5 7, 2015 DoubleTree by Hilton Hotel Zagreb, Ulica Grada Vukovara 269a, Zagreb, Croatia Organizers: MS Research Association Croatia Referral Centre for Demyelinating Diseases of the CNS, Department
More informationfriday 30 may 2008 brussels belgium Sheraton Brussels Hotel Place Rogier 3 Rogierplein B- 1210 Brussels
friday 30 may 2008 brussels belgium 1 ST Belgian Congress on Acute Cardiac Care Sheraton Brussels Hotel Place Rogier 3 Rogierplein B- 1210 Brussels Dear Colleagues, On behalf of the Belgian Interdisciplinary
More informationTarget audience. Physicians and other health care professionals working in reproductive health centres.
Mail to: Meridiano Congress International Att: Denise Rizzitelli Via Mentana 2/B 00185 Rome Italy Mail to: Meridiano Congress International Att: Denise Rizzitelli Via Mentana 2/B 00185 Rome Italy Aim
More informationParis 12 th December 2014
Hammersmith Hospital 1 st UK-France workshop on metastatic colorectal cancer Paris 12 th December 2014 Georges Pompidou European Hospital Vessels and cancer: from intra-arterial treatment to tumour angiogenesis
More informationMagnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
More informationSTATE OF THE ART INVITATION SATURDAY, JANUARY 30 TH, 2016 COMORBIDITIES AND ENVIRONMENTAL FACTORS INFLUENCING MULTIPLE SCLEROSIS
18 TH STATE OF THE ART SYMPOSIUM of the Swiss Multiple Sclerosis Society www.multiplesklerose.ch INVITATION SATURDAY, JANUARY 30 TH, 2016 KKL Luzern, Culture and Convention Centre COMORBIDITIES AND ENVIRONMENTAL
More informationPromises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
More informationScientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
More informationACCORD PROJECT FINAL RESULTS OF THE. 2 nd June, 2015. Rafael Matesanz, on behalf of the ACCORD consortium. Director
FINAL RESULTS OF THE ACCORD PROJECT 2 nd June, 2015 Auditorium MUTUA MADRILEÑA Foundation, MADRID Director Rafael Matesanz, on behalf of the ACCORD consortium Achieving Comprehensive Coordination in Organ
More informationThe Copernican Revolution in Ischemic Heart Diseases: the day after
Menarini Foundation Symposia: 249 The Copernican Revolution in Ischemic Heart Diseases: the day after Pisa (Italy), June 27 th 28 th, 2014 Organized by POSTGRADUATE SCHOOL OF CARDIOVASCULAR MEDICINE UNIVERSITY
More informationLIQUID BIOPSY: TRACKING CANCER
SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 first announcement Pierre-Auguste Renoir Chemin montant dans les hautes herbes Organizing Secretariat CONGRESS LINE Via Cremona, 19-00161 Rome
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
More informationMagnetic Resonance Techniques in Multiple Sclerosis
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita - Salute San Raffaele University
More informationGLOBAL SURVEY FACT SHEET
Multiple sclerosis (MS) is a chronic, often disabling, disease that attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild or severe, ranging
More informationGlobal Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070277/ Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
More informationPromises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
More informationBiogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
More informationON CLINICAL PHARMACOLOGY OF ANTIRETROVIRALS 10 RESIDENTIAL COURSE. 21-22-23 January 2015. Starhotels Majestic. corso Vittorio Emanuele II 54 - TURIN
TH 10 RESIDENTIAL COURSE ON CLINICAL PHARMACOLOGY OF ANTIRETROVIRALS 2005 2006 2007 Starhotels Majestic corso Vittorio Emanuele II 54 - TURIN 2009 2010 2011 2012 2013 2014 21-22-23 January 2015 TH 10
More informationAOSpine Masters Symposium Adult deformity of the cervical, thoracic and lumbar spine
EUROPE Event program AOSpine Masters Symposium Adult deformity of the cervical, thoracic and lumbar spine June 13 14, 2014 Florence, Italy June 13 14, 2014 Florence, Italy 3 Dear AOSpine Participant On
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationSPONSOR AND EXHIBITOR INFORMATION
SPONSOR AND EXHIBITOR INFORMATION For the 10th European Mucosal Immunology Group Meeting 19-21 October 2016 Copenhagen, Denmark www.emig2016.org WELCOME Dear colleagues, It is a great honour to host and
More informationß-interferon and. ABN Guidelines for 2007 Treatment of Multiple Sclerosis with. Glatiramer Acetate
ABN Guidelines for 2007 Treatment of Multiple Sclerosis with ß-interferon and Glatiramer Acetate Published by the Association of British Neurologists Ormond House, 27 Boswell Street, London WC1N 3JZ Contents
More informationCommunication in the digital age - How mutuals can deliver quality content and engage with customers and the media.
Communication in the digital age - How mutuals can deliver quality content and engage with customers and the media. Day 1 Thursday, 22 October 2015 Barcelona 15:00 15:30 Welcome coffee and registration
More informationMedia Release. Basel, 8 October 2015
Media Release Basel, 8 October 2015 Roche s ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary progressive forms of multiple sclerosis Ocrelizumab
More informationIPMSC First Scientific Conference Daily Program
IPMSC First Scientific Conference Daily Program February 6 th 2013 19:30 Welcome dinner at the NH Milano 2 Hotel February 7 th 2013 Meeting Venue: San Raffaele Congress Centre - Caravella Santa Maria Room
More informationEMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston
Erin-Marie Beals Phone 1-781-681-2850 September 9, 2014 EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston Data include
More informationPOST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013
20 th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine 45 th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) POST-CONGRESS SATELLITE
More informationOntario Reimburses CIS Indication for REBIF, a First-Line Treatment for Multiple Sclerosis
May 25, 2015 Contact: Shikha Virdi 905-919-0200 ext. 5504 Ontario Reimburses CIS Indication for REBIF, a First-Line Treatment for Multiple Sclerosis Rebif now reimbursed under Ontario Drug Benefit Program
More informationSinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast
More informationSUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,
More informationCARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM
Sesto San Giovanni PRELIMINARY PROGRAM PRESIDENTS Sesto San Giovanni G. J. Klein University Hospital Card Inv Unit London Ontario Canada A. S. Montenero IRCCS Multimedica Cardiology Dpt. Sesto San Giovanni
More informationStem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS
Preliminary Programme INTERNATIONAL CONFERENCE Promoted by: Consiglio Nazionale delle Ricerche In collaboration with Stem cells: the diverging goals of regenerative medicine and oncology CHAIRMEN: KENNETH
More informationHaploidentical Stem Cell Transplantation
UNIVERSITÀ DEGLI STUDI DI PARMA Preliminary Program 8 th International Symposium on Haploidentical Stem Cell Transplantation Chairman Co-Chairpersons Massimo F. Martelli, Yair Reisner Parma 4-6 September
More informationGenomics in Hematology
Università degli Studi di Perugia Genomics in Hematology January 29-31, 2012 Perugia Camera di Commercio Congress Center January 29 th, 2012 Opening Session Teatro del Pavone Chairs: Franco Aversa, Cristina
More informationon End Stage Focus on Idiopathic
II International Conference on End Stage Lung DiseaseS: Focus on Idiopathic Pulmonary Fibrosis Padua - Italy, February 22 nd, 2013 Palazzo del Bo - Aula Nievo ENDORSEMENTS WELCOME TO PADUA Italian Association
More informationTwo-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with Multiple Sclerosis
Your contact News Release Barbara Fry Phone +1 905 919 0163 April 29/30, 2009 Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with Multiple
More informationMAY 8-9 2015 AUDITORIUM DEL SERAPHICUM. Via del Serafico, 1 - ROME - ITALY PRELIMINARY PROGRAM. Chairman: Giovanni Di Giacomo, MD
MAY 8-9 2015 AUDITORIUM DEL SERAPHICUM Via del Serafico, 1 - ROME - ITALY PRELIMINARY PROGRAM Chairman: Giovanni Di Giacomo, MD DAY 1 14.30-14.40 PRESENTATION MAY 8 - FRIDAY AFTERNOON (G. Di Giacomo -
More informationpulmonary hypertension bologna 2012 Royal Hotel Carlton - Bologna - Italy Under the aegis of alma mater studiorum università di bologna
Under the aegis of alma mater studiorum università di bologna dipartimento cardiovascolare pulmonary hypertension bologna 2012 Royal Hotel Carlton - Bologna - Italy November 23-24, 2012 Friday, november
More informationInternational Conference on Clinical PET CT and Molecular Imaging: PET CT in the Era of Multimodality Imaging and Image Guided Therapy (IPET-2015)
International Conference on Clinical PET CT and Molecular Imaging: PET CT in the Era of Multimodality Imaging and Image Guided Therapy (IPET-2015) IAEA Headquarters Vienna, Austria 5 9 October 2015 Ref.
More informationGlobal Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070278/ Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
More informationTHE PRESENT AND THE FUTURE OF FERTILITY PRESERVATION
International Society for Fertility Preservation FONDAZIONE PER GLISTUDI SULLA RIPRODUZIONE UMANA November 2 nd 2012 Hands-on: Gamete and Tissue Cryopreservation Venue:Clinica Candela Hands-on: Natural
More informationTravel Medicine 2016. Travel Medicine Vaccines & Therapeutics. Brochure. International Conference on. Travel Medicine 2016
International Conference on Travel Medicine Vaccines & Therapeutics New Orleans, USA August 01-02, 2016 Brochure Conference Secretariat 2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA Ph:
More informationGlobal Haemophilia Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070298/ Global Haemophilia Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of its Haemophilia
More informationRegional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
More informationThe Management. 15 th December, VENICE Hotel Palazzo Giovanelli Santa Croce, San Stae, 2070. Workshop on
INTERNATIONAL CLUB OF ASCITES Workshop on The Management of Renal Dysfunction in Patients with Cirrhosis 14 th December, PADUA Aula Morgagni Policlinico Universitario Via Giustiniani 2 15 th December,
More informationMultiple Sclerosis: Current Treatments and Future Promise
Joseph P. Van Der Meulen Symposium in Clinical Neuroscience Multiple Sclerosis: Current Treatments and Future Promise Saturday, May 12, 2012 Louis B. Mayer Auditorium USC Health Sciences Campus Los Angeles,
More informationData include post-hoc assessments of controlled studies in relapsing MS regarding evolution of
September 10, 2014 Contact: Shikha Virdi 905-919-0200 ext. 5504 EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston Data
More informationPSA Screening and the USPSTF Understanding the Controversy
PSA Screening and the USPSTF Understanding the Controversy Peter C. Albertsen Division of Urology University of Connecticut Farmington, CT, USA USPSTF Final Report 1 Four Key Questions 1. Does PSA based
More informationCachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.
REPORT Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F. Strasser, CH 13-14 March 2015 Barcelona, Spain The Conference Cachexia
More informationFirst Announcement. 2 6 November 2014 Scottish Exhibition and Conference Centre Glasgow, UK. Joint Academic Sponsors
2 6 November 2014 Scottish Exhibition and Conference Centre Glasgow, UK First Announcement Joint Academic Sponsors University College London Medical School (UCLMS), UK Karolinska Institutet Stockholm Sweden
More informationAORTA MASTERCLASS 2015 Preliminary Programme
DAY 1 THURSDAY, 08 th October, 2015 09:30 Registration, tea and coffee 10:00 Welcome B. Sethia - President of The Royal Society of Medicine / RSM, London, UK 10:05 Introduction T. Evans / Royal Brompton
More informationINTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015
LS LS Magna Gr ae cia University of Catanzaro, Italy Preliminary Program PhD PROGRAMME PhD PROGRAMME MOLECULAR AND TRANSLATIONAL ONCOLOGY LIFE SCIENCES ORGANIZING COMMITTEE Professor Ennio Carbone Head
More informationDrug Safety of Stem Cells and other Novel Therapeutics
Course 1.2 Drug Safety of Stem Cells and other Novel Therapeutics 13 17 October 2014 MRC Centre for Drug Safety Science Institute of Translational Medicine University of Liverpool, Liverpool, UK European
More informationOPTIMISING PATIENT OUTCOMES THROUGH PHYSICIAN EDUCATION
OPTIMISING PATIENT OUTCOMES THROUGH PHYSICIAN EDUCATION Anita Seaford MARCH 2015 IN ASSOCIATION WITH CONTENTS 01 Executive Summary 02 Introducing the survey 03 How European cardiologists currently educate
More informationMULTIPLE SCLEROSIS PHYSICIAN RESOURCES
MULTIPLE SCLEROSIS PHYSICIAN RESOURCES This resource provides internet links that may be of interest to your patients diagnosed with multiple sclerosis. Many of these links will provide invaluable information
More informationMultiple Sclerosis in Practice. An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report
Multiple Sclerosis in Practice An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report Clinical Context: Multiple Sclerosis in Practice Expert Commentary Jointly Sponsored by: and Clinical
More informationA LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES
A LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES Milan (Italy), June 5 th - 6 th, 2015 Auditorium Don Giacomo Alberione Via Giotto, 36 Organized by MILANO CORD
More informationWhat s New in Rhinology 2012
What s New in Rhinology 2012 Guests of Honour Valerie J. Lund, London - UK Peter-John Wormald, Adelaide - AU Faculty Mario Bussi, Milano - IT Paolo Castelnuovo, Varese - IT Piero Nicolai, Brescia - IT
More informationScientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
More informationLife with MS: Mastering Early Treatment
Life with MS: Mastering Early Treatment Essential Information About MS Multiple sclerosis (MS) is a disease that attacks the central nervous system (CNS). Approximately 2.5 million people worldwide and
More informationDepartment of Neurology and Neurosurgery Clinical and Clinical Research Fellowship Application Form
Department of Neurology and Neurosurgery Clinical and Clinical Research Fellowship Application Form Fellowship in Multiple Sclerosis and Neuroinflammatory Disorders Type of Fellowship: Clinical Research
More informationDecision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
More informationTraining for European Sustainable Tourism (T4EST)
Training for European Sustainable Tourism (T4EST) 527521-LLP-1-2012-1-IT-LEONARDO-LAM 1 Project Information Title: Project Number: Training for European Sustainable Tourism (T4EST) 527521-LLP-1-2012-1-IT-LEONARDO-LAM
More information9th World Congress on Prevention of Diabetes and its Complications. 2-4, December 2016 WWW.wcpd9.com. Georgia World Congress Centre, Atlanta, USA
9th World Congress on Prevention of Diabetes and its Complications 2-4, December 2016 WWW.wcpd9.com Georgia World Congress Centre, Atlanta, USA Welcome Messages Diabetes is one of the fastest growing public
More informationFIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE. Porto Pirgos Hotel (www.portopirgos.com), Parghelia (VV), Calabria, Italy
FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE Porto Pirgos Hotel (www.portopirgos.com), Parghelia (VV), Calabria, Italy 22-25 September, 2004 Under the Auspices of the Calabria
More informationhttps://www.kent.edu/cpm/2015-florence-italy A Continuing Medical Education Podiatric Conference
https://www.kent.edu/cpm/2015-florence-italy A Continuing Medical Education Podiatric Conference United States Kent State University College of Podiatric Medicine is approved by the Council on Podiatric
More informationFOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES
FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES Siena, November 4-5, 2004 AUSPICES SIE SIES University of Siena Department of Medicine and Immunological Sciences Section of Hematology and Transplantion,
More informationVoting for your top research questions Survey
MS Priority Setting Partnership Voting for your top research questions Survey Prioritising important research questions for multiple sclerosis a partnership between people affected by MS and healthcare
More informationNutrition support in neurodegenerative diseases
ESPEN Congress Leipzig 2013 The ESPEN Guidelines session Nutrition support in neurodegenerative diseases R. Burgos (ES) ESPEN GUIDELINES ON NUTRITION SUPPORT IN NEURODEGENERATIVE DISORDERS Dr. Rosa Burgos
More information10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in
More informationA LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES
A LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES Milan (Italy), June 5th - 6th, 2015 Auditorium Don Giacomo Alberione Via Giotto, 36 Organized by MILANO CORD BLOOD
More information9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) Szeged,
More informationWelcome. AO Global Spine Congress Instructional Course Lectures.
Welcome. AO Global Spine Congress Instructional Course Lectures. March 23 26, 2011 Barcelona, Spain Level -1 Room H1 AO Global Spine Congress Synthes highlights at a glance Dear participant, Synthes welcomes
More informationKey Advances in Stroke Rehabilitation
Conference on Key Advances in Stroke Rehabilitation 12th June 2013 Organised by: Congress Centre, London United Kingdom Limited spaces available Key Advances in Stroke Rehabilitation About the conference
More informationTreatment in Relapsing MS: Choosing Among the Options. Donald Negroski, MD
Treatment in Relapsing MS: Choosing Among the Options Donald Negroski, MD Disclosures Research Grants Educational activities and lectures Consulting or other services including Continuing Medical Education
More informationMonday 27 th October 2014 12,00-14,00 Registration 12,30-14,00 Welcome Buffet
Scientific Committee Paolo Rossi (President, Rome, Italy); Marco Cappa (Chair, Rome, Italy); Stefano Cianfarani (Rome, Italy); George P. Chrousos (Athens, Greece); Lucia Ghizzoni (Turin, Italy) Sandro
More informationPROGRAM GENETIC AND EPIGENETIC ANALYSES OF HUMAN EMBRYOS: PAST, PRESENT AND FUTURE
PROGRAM Thursday, September 17 h 15.00 I SESSION GENETIC AND EPIGENETIC ANALYSES OF HUMAN EMBRYOS: PAST, PRESENT AND FUTURE Chairmen: Carlo Flamigni (Bologna, Italy) - Sebastiano Bianca (Catania, Italy)
More information2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
More informationRational basis for early treatment in MS. Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València
Rational basis for early treatment in MS Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València Bonaventura Casanova Department of Neurology University Hospital La
More informationA Handbook for Planning Committees Developing Educational Programs
A Handbook for Planning Committees Developing Educational Programs Approved October 23, 2012 Educational Program Development Cycle Step 1 Convene planning committee Step 8 Review the evaluation results
More informationMultiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
More informationThe Importance of Educational Access for MS Nurses: Integrating Knowledge & Skills MS Nurse PROfessional
The Importance of Educational Access for MS Nurses: Integrating Knowledge & Skills MS Nurse PROfessional Vicki Matthews, RIMS Specialist Nurse Advisor This activity is supported by educational grants from:
More informationWorkshop on multiple sclerosis
7 October 2013 EMA/263897/2013 Scientific and Regulatory Management Department Final programme 17 October 2013 European Medicines Agency, London, United Kingdom Room 2A 7 Westferry Circus Canary Wharf
More informationSection 1. Section 2. 2.1. Venue... 6 2.2. Registration. 6 2.3. Acknowledgement of Funding... 6. V: 04.04.16 1 of 6
PROGRAMME 18 th 19 th April 2016 Freiburg, Germany Contents Section 1 1.1. Foreword from Dr Valayannopoulos, Chair, ETAC.. 2 1.2. Learning Objectives 2 1.3. Organising Committee 3 1.4. Faculty Members...
More informationBREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano
Centro di Senologia della Svizzera Italiana 8 th Edition BREAST CANCER IN YOUNG WOMEN OCTOBER 9 th Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano Scientific Coordinators: Olivia Pagani and Alberto
More informationMultiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
More informationMerck Serono UK Disclosure for 2014
Merck Serono UK Disclosure for 2014 Merck Serono are committed to ensuring transparency of its relationship with healthcare professional and in its collaborations with other organisations. We specifically
More informationEnabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV
Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute
More informationMethotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Brochure More information from http://www.researchandmarkets.com/reports/3128342/ Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Description: Methotrexate (Rheumatoid Arthritis)
More information